Literature DB >> 15001535

DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.

Erika Gyorffy1, Lívia Anna, Zoltán Gyori, Judit Segesdi, János Minárovits, Ibolya Soltész, Szilárd Kostic, Attila Csekeo, Miriam C Poirier, Bernadette Schoket.   

Abstract

Smoking is a major risk factor for lung cancer. This comparative study of smoking-related carcinogen-DNA adducts in pulmonary tissues and peripheral blood lymphocytes aims to further explore the primary DNA damaging processes by cigarette smoke in target and surrogate tissues. Samples of tumour and normal peripheral lung tissue, normal bronchial tissue and peripheral blood lymphocytes were obtained from a total of 85 lung cancer patients who underwent lung resection. Bulky DNA adducts were determined by 32P-postlabelling, and polycyclic aromatic hydrocarbon (PAH)-DNA adducts were detected by (+/-)-7beta, 8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-DNA chemiluminescence immunoassay (BPDE-DNA CIA) in smaller subsets of tissue samples subject to availability of DNA. Bulky DNA adduct levels ranged between 0.3 and 27.8 adducts/10(8) nucleotides (nt) with mean adduct levels between 2.8 and 11.5 adducts/10(8) nt. Mean PAH-DNA adduct levels were 2.6-6.2 adducts/10(8) nt. Significantly higher bulky DNA adduct levels were detected in smokers' lungs as compared with non-smokers' (P < 0.02). PAH-DNA adduct levels appeared higher in the lungs of smokers compared with non-smokers but the difference was not significant. Lung tumour contained on average a 50% lower DNA adduct level compared with normal lung tissue. A statistically significant positive correlation was found between the DNA adduct levels of the corresponding tumour and normal lung tissue samples in both smokers and non-smokers using both methodologies. Bulky DNA adduct levels in normal lung and blood lymphocytes correlated significantly in non-smokers only (r = 0.55, P = 0.023). In lung tumour DNA samples there was a weak correlation between values obtained by 32P-postlabelling and by the BPDE-DNA immunoassay (r = 0.27, P = 0.054). However, with normal lung DNA samples, values obtained by the two assays did not correlate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001535     DOI: 10.1093/carcin/bgh131

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

Review 1.  Acrolein induced DNA damage, mutagenicity and effect on DNA repair.

Authors:  Moon-shong Tang; Hsiang-tsui Wang; Yu Hu; Wei-Sheng Chen; Makoto Akao; Zhaohui Feng; Wenwei Hu
Journal:  Mol Nutr Food Res       Date:  2011-06-29       Impact factor: 5.914

2.  Development and validation of a direct sandwich chemiluminescence immunoassay for measuring DNA adducts of benzo[a]pyrene and other polycyclic aromatic hydrocarbons.

Authors:  Panagiotis Georgiadis; Katalin Kovács; Stella Kaila; Paraskevi Makedonopoulou; Livia Anna; Miriam C Poirier; Lisbeth E Knudsen; Bernadette Schoket; Soterios A Kyrtopoulos
Journal:  Mutagenesis       Date:  2012-05-18       Impact factor: 3.000

3.  Neighborhood socioeconomic status modifies the association between individual smoking status and PAH-DNA adduct levels in prostate tissue.

Authors:  Andrew Rundle; Catherine Richards; Christine Neslund-Dudas; Deliang Tang; Benjamin A Rybicki
Journal:  Environ Mol Mutagen       Date:  2012-03-29       Impact factor: 3.216

4.  Methyl DNA phosphate adduct formation in lung tumor tissue and adjacent normal tissue of lung cancer patients.

Authors:  Bin Ma; Peter W Villalta; J Bradley Hochalter; Irina Stepanov; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2019-11-25       Impact factor: 4.944

Review 5.  DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol.

Authors:  Moon-Shong Tang; Hyun-Wook Lee; Mao-Wen Weng; Hsiang-Tsui Wang; Yu Hu; Lung-Chi Chen; Sung-Hyun Park; Huei-Wei Chan; Jiheng Xu; Xue-Ru Wu; He Wang; Rui Yang; Karen Galdane; Kathryn Jackson; Annie Chu; Elizabeth Halzack
Journal:  Mutat Res Rev Mutat Res       Date:  2021-12-20       Impact factor: 7.015

6.  Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Michelle Jankowski; Sheri Trudeau; Andrew Rundle; Benjamin A Rybicki
Journal:  Carcinogenesis       Date:  2012-10-12       Impact factor: 4.944

7.  Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons.

Authors:  Sofia Pavanello; Angela-C Pesatori; Laura Dioni; Mirjam Hoxha; Valentina Bollati; Ewa Siwinska; Danuta Mielzyńska; Claudia Bolognesi; Pier-Alberto Bertazzi; Andrea Baccarelli
Journal:  Carcinogenesis       Date:  2009-11-05       Impact factor: 4.944

Review 8.  Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma.

Authors:  Gholamreza Roshandel; Shahryar Semnani; Reza Malekzadeh; Sanford M Dawsey
Journal:  Arch Iran Med       Date:  2012-11       Impact factor: 1.354

9.  Polycyclic aromatic hydrocarbon--DNA adducts in prostate and biochemical recurrence after prostatectomy.

Authors:  Benjamin A Rybicki; Christine Neslund-Dudas; Cathryn H Bock; Andrew Rundle; Adnan T Savera; James J Yang; Nora L Nock; Deliang Tang
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

10.  Detection of BPDE-DNA adducts in human umbilical cord blood by LC-MS/MS analysis.

Authors:  Ling Guo; Xiao Jiang; Hao-Yuan Tian; Shang-Jin Yao; Bo-Ya Li; Rong-Jie Zhang; Shu-Sheng Zhang; Xin Sun
Journal:  J Food Drug Anal       Date:  2019-03-23       Impact factor: 6.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.